UM  > Faculty of Health Sciences
Residential Collegefalse
Status已發表Published
Preclinical evidence using synthetic compounds and natural products indicates that AMPK represents a potential pharmacological target for the therapy of pulmonary diseases
Yang, Chao1; Rubin, Limor2; Yu, Xiyong3; Lazarovici, Philip4; Zheng, Wenhua1
Source PublicationMedicinal Research Reviews
ISSN0198-6325
2024-05-01
Abstract

Adenosine 5′-monophosphate (AMP)-activated protein kinase (AMPK) is a highly conserved eukaryotic enzyme discovered as a key regulator of cellular energy homeostasis, with anti-inflammation, antioxidative stress, anticancer, and antifibrosis beneficial effects. AMPK is dysregulated in human pulmonary diseases such as acute lung injury, nonsmall cell lung cancer, pulmonary fibrosis, chronic obstructive pulmonary disease, and asthma. This review provides an overview of the beneficial role of natural, synthetic, and Chinese traditional medicines AMPK modulators in pulmonary diseases, and highlights the role of the AMPK signaling pathway in the lung, emphasizing the importance of finding lead compounds and drugs that can target and modulate AMPK to treat the lung diseases.

KeywordAli Ampk Copd Nsclc Pf
Language英語English
DOI10.1002/med.22014
URLView the original
Volume44
Issue3
Pages1326-1369
WOS IDWOS:001143117700001
WOS SubjectChemistry, Medicinal ; Pharmacology & Pharmacy
WOS Research AreaPharmacology & Pharmacy
Indexed BySCIE
Scopus ID2-s2.0-85182487811
Fulltext Access
Citation statistics
Document TypeReview article
CollectionFaculty of Health Sciences
DEPARTMENT OF PHARMACEUTICAL SCIENCES
Corresponding AuthorZheng, Wenhua
Affiliation1.Faculty of Health Sciences, University of Macau, Taipa, Macao
2.Allergy and Clinical Immunology Unit, Department of Medicine, Jerusalem, Israel
3.School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, China
4.School of Pharmacy Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel
First Author AffilicationFaculty of Health Sciences
Corresponding Author AffilicationFaculty of Health Sciences
Recommended Citation
GB/T 7714
Yang, Chao,Rubin, Limor,Yu, Xiyong,et al. Preclinical evidence using synthetic compounds and natural products indicates that AMPK represents a potential pharmacological target for the therapy of pulmonary diseases[J]. Medicinal Research Reviews, 2024, 44(3), 1326-1369.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Yang, Chao]'s Articles
[Rubin, Limor]'s Articles
[Yu, Xiyong]'s Articles
Baidu academic
Similar articles in Baidu academic
[Yang, Chao]'s Articles
[Rubin, Limor]'s Articles
[Yu, Xiyong]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Yang, Chao]'s Articles
[Rubin, Limor]'s Articles
[Yu, Xiyong]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.